sec filing
XC
NASDAQ · XCUR
Exicure, Inc.
Healthcare · Biotechnology
$1.43
Up+$0.05 (+3.62%)
Updated Aug 19, 2026, 12:52 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.07M
- P/E ratio
- -4.91
- Dividend yield
- 0.00%
- 52-week range
- $1.18 – $9.48
- Volume
- 28.47K
- Avg. volume
- 653.33K
Price performance
XCUR price history
1M range · 21 trading sessions · Daily adjusted prices
XCUR closed at $1.43 after 21 trading sessions, down 25.91% for the selected period.
- Last close
- $1.43
- Period change
- -25.91%
- Period low
- $1.25
- Period high
- $1.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $1.35 | $1.48 | $1.35 | $1.43 | 28.47K |
| Aug 17, 2026 | $1.26 | $1.42 | $1.26 | $1.38 | 52.24K |
| Aug 14, 2026 | $1.33 | $1.33 | $1.25 | $1.25 | 21.94K |
| Aug 13, 2026 | $1.31 | $1.35 | $1.18 | $1.31 | 54.29K |
| Aug 12, 2026 | $1.40 | $1.40 | $1.30 | $1.30 | 17.65K |
| Aug 11, 2026 | $1.36 | $1.4399 | $1.33 | $1.40 | 37.23K |
| Aug 10, 2026 | $1.33 | $1.43 | $1.285 | $1.37 | 60.02K |
| Aug 7, 2026 | $1.35 | $1.43 | $1.269 | $1.345 | 39.99K |
| Aug 6, 2026 | $1.46 | $1.46 | $1.30 | $1.35 | 56.5K |
| Aug 5, 2026 | $1.50 | $1.55 | $1.42 | $1.51 | 28.56K |
| Aug 4, 2026 | $1.61 | $1.63 | $1.5106 | $1.54 | 70.53K |
| Aug 3, 2026 | $1.52 | $1.64 | $1.50 | $1.58 | 52.22K |
| Jul 31, 2026 | $1.65 | $1.65 | $1.55 | $1.60 | 17.7K |
| Jul 30, 2026 | $1.74 | $1.74 | $1.57 | $1.57 | 64.14K |
| Jul 29, 2026 | $1.71 | $1.81 | $1.695 | $1.73 | 26.76K |
| Jul 28, 2026 | $1.68 | $1.79 | $1.59 | $1.74 | 46.46K |
| Jul 27, 2026 | $1.72 | $1.7745 | $1.57 | $1.75 | 19.18K |
| Jul 24, 2026 | $1.71 | $1.77 | $1.66 | $1.76 | 53K |
| Jul 23, 2026 | $1.67 | $1.86 | $1.6505 | $1.71 | 54.16K |
| Jul 22, 2026 | $1.87 | $1.94 | $1.70 | $1.76 | 57.85K |
| Jul 21, 2026 | $1.77 | $2.00 | $1.77 | $1.93 | 139.1K |
Latest XCUR news
The latest Smart Investors Daily articles mentioning XCUR.
Stock researchCompany · Financials
Loading stock research…